The Oncology Institute, Inc.
TOI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $33 | $14 | $114 |
| Short-Term Investments | $0 | $49 | $60 | $0 |
| Receivables | $49 | $43 | $40 | $21 |
| Inventory | $10 | $14 | $9 | $6 |
| Other Curr. Assets | $4 | $4 | $7 | $12 |
| Total Curr. Assets | $112 | $143 | $130 | $154 |
| Property Plant & Equip (Net) | $38 | $40 | $33 | $4 |
| Goodwill | $7 | $7 | $21 | $27 |
| Intangibles | $15 | $18 | $18 | $18 |
| Long-Term Investments | $0 | $0 | $58 | -$0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $60 | $66 | $131 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $173 | $209 | $262 | $203 |
| Liabilities | – | – | – | – |
| Payables | $24 | $14 | $9 | $16 |
| Short-Term Debt | $7 | $6 | $5 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $5 | $1 | $1 | $1 |
| Other Curr. Liab. | $16 | $13 | $13 | $13 |
| Total Curr. Liab. | $52 | $35 | $30 | $30 |
| LT Debt | $116 | $113 | $103 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $4 | $6 | $69 |
| Total NC Liab. | $117 | $117 | $109 | $69 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $30 | $33 | $28 | $0 |
| Total Liabilities | $169 | $152 | $138 | $99 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$211 | -$146 | -$63 | -$63 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $214 | $203 | $186 | $167 |
| Total Equity | $4 | $57 | $123 | $104 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $173 | $209 | $262 | $203 |
| Net Debt | $73 | $86 | $94 | -$114 |